Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jasper Rymenants"'
Autor:
Jana Van Dycke, Wenhao Dai, Zoe Stylianidou, Jian Li, Arno Cuvry, Emma Roux, Bingqian Li, Jasper Rymenants, Lindsey Bervoets, Peter de Witte, Hong Liu, Johan Neyts, Joana Rocha-Pereira
Publikováno v:
Viruses, Vol 13, Iss 9, p 1852 (2021)
Human noroviruses (HuNoVs) are the most common cause of viral gastroenteritis resulting annually in ~219,000 deaths and a societal cost of ~USD 60 billion, and no antivirals or vaccines are available. Here, we assess the anti-norovirus activity of ne
Externí odkaz:
https://doaj.org/article/a4ae9d5cb59a4e8db1379b4b9612adf8
Autor:
Jana Van Dycke, Michela Puxeddu, Giuseppe La Regina, Eloise Mastrangelo, Delia Tarantino, Jasper Rymenants, Jessica Sebastiani, Marianna Nalli, Jelle Matthijnssens, Johan Neyts, Romano Silvestri, Joana Rocha-Pereira
Publikováno v:
Pharmaceuticals, Vol 14, Iss 10, p 1006 (2021)
Human noroviruses (HuNoVs) are the most common cause of viral gastroenteritis resulting in ~219,000 deaths annually and a societal cost of ~USD60 billion. There are no antivirals or vaccines available to treat and/or prevent HuNoV. In this study, we
Externí odkaz:
https://doaj.org/article/67a5e148492f472c90bbc00a58b6c0e3
Autor:
Daniel A. Foucher, Jasper Rymenants, Youry Kim, Damian F. J. Purcell, Julie L. McAuley, Alex Caschera
Publikováno v:
American Journal of Infection Control
Background: The COVID-19 pandemic has had an unprecedented impact on global health and the world's economies. Proliferation of virulent and deadly SARS-CoV-2 variants require effective transmission mitigation strategies. Under reasonable environmenta
Autor:
Giuseppe La Regina, Jasper Rymenants, Romano Silvestri, Jana Van Dycke, Jessica Sebastiani, Michela Puxeddu, Eloise Mastrangelo, Marianna Nalli, Joana Rocha-Pereira, Jelle Matthijnssens, Delia Tarantino, Johan Neyts
Publikováno v:
Pharmaceuticals, Vol 14, Iss 1006, p 1006 (2021)
Pharmaceuticals
Volume 14
Issue 10
Pharmaceuticals
Volume 14
Issue 10
Human noroviruses (HuNoVs) are the most common cause of viral gastroenteritis resulting in ~219,000 deaths annually and a societal cost of ~USD60 billion. There are no antivirals or vaccines available to treat and/or prevent HuNoV. In this study, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24b71ce87e6d042838b4c6abd012ac90
https://lirias.kuleuven.be/handle/123456789/683281
https://lirias.kuleuven.be/handle/123456789/683281
Publikováno v:
Antiviral Chemistry & Chemotherapy, Vol 29 (2021)
Antiviral Chemistry & Chemotherapy
Antiviral Chemistry & Chemotherapy
Human norovirus is the main cause of viral gastroenteritis, resulting annually in ∼ 700 million infections and 200,000 deaths, of whom most are children
Publikováno v:
Antiviral Chemistry & Chemotherapy
Antiviral Chemistry & Chemotherapy, Vol 29 (2021)
Antiviral Chemistry & Chemotherapy, Vol 29 (2021)
Human norovirus is the main cause of viral gastroenteritis, resulting annually in ∼ 700 million infections and 200,000 deaths, of whom most are children
Autor:
Joana Rocha-Pereira, Karine Barthélémy, Sebastiaan ter Horst, Kai Dallmeier, Pieter Annaert, Laurens Liesenborghs, Lindsey Bervoets, Caroline Solas, Bart Hens, Patrick Augustijns, Robbert Boudewijns, Tina Van Buyten, Juanita Pang, Judith Breuer, Elisabeth Heylen, Carolien De Keyzer, Birgit Weynand, Hendrik Jan Thibaut, Lana Langendries, Rana Abdelnabi, Isabel Spriet, Jasper Rymenants, Johan Neyts, Valentijn Vergote, Xin Zhang, Nick Verougstraete, Greetje Vande Velde, Sofie Jacobs, Leen Delang, Christopher Cawthorne, Laura Seldeslachts, Elke Maas, Jens Wouters, Rachel Williams, Suzanne J.F. Kaptein
Publikováno v:
Proceedings of the National Academy of Sciences
Proceedings of the National Academy of Sciences of the United States of America
Proceedings of the National Academy of Sciences of the United States of America
Significance The previous lack of consensus around the use of hydroxychloroquine for COVID-19 patients underlines the need to thoroughly assess the in vivo efficacy of drugs against SARS-CoV-2. Small animal infection models, such as the hamster model
Autor:
Elisabeth Heylen, Joana Rocha-Pereira, Pieter Annaert, Robbert Boudewijns, Leen Delang, Isabel Spriet, Laura Seldeslachts, Valentijn Vergote, Lindsey Bervoets, Suzanne J.F. Kaptein, Jasper Rymenants, Bart Hens, Greetje Vande Velde, Nick Verougstraete, Patrick Augustijns, Sofie Jacobs, Christopher Cawthorne, Tina Van Buyten, Johan Neyts, Elke Maas, Sebastiaan ter Horst, Kai Dallmeier, Birgit Weynand, Jens Wouters, Carolien De Keyzer, Hendrik Jan Thibaut, Lana Langendries, Laurens Liesenborghs
SARS-CoV-2 rapidly spread around the globe after its emergence in Wuhan in December 2019. With no specific therapeutic and prophylactic options available, the virus was able to infect millions of people. To date, close to half a million patients succ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::542e8836825861e7d581a4f36fc9b81a
https://doi.org/10.1101/2020.06.19.159053
https://doi.org/10.1101/2020.06.19.159053